HALO logo
halo search icon
Harvard Bioscience, Inc.

US$5.40

Price Change Indicator
0.39 (7.78%)
Harvard Bioscience, Inc.
HBIO · NAS

Harvard Bioscience, Inc.

Start Trading HBIO for Free

US$5.40

Price Arrow0.39 (7.78%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Harvard Bioscience, Inc. Overview

HBIO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About HBIO

icon
icon

Telephone

1.508.893.8999

icon

Address

Suite 10, 84 October Hill Road, Holliston, MA 01746-1371

Description

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, China, United Kingdom, and Rest of the World. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

HBIO Price Chart

Key Stats

Market Cap

US$22.60M

PE

16.90

EV/EBITDA

9.4

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.81 - 9.46

Trade Value (12mth)

US$770,633.00

1 week

-4.57%

1 month

-23.63%

YTD

-23.15%

1 year

53.59%

All time high

87.50

Key Fundamentals

EPS 3 yr Growth

455.90%

EBITDA Margin

7.00%

Operating Cashflow

$7m

Free Cash Flow Return

10.70%

ROIC

-89.90%

Interest Coverage

1.20

Quick Ratio

1.20

Other Data

Shares Outstanding (Fully Diluted)

4m

HALO Sector

Healthcare

Next Company Report Date

11-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

HBIO Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
13 May 26
12 May 26
12 May 26

HBIO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.8-2.85-12.77locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.8-2.85-12.77locklocklock
Growth
 %locklocklocklock65-253.9-348.3locklocklock
PE
 Xlocklocklocklock26.216.916.9locklocklock
EV/EBITDA
 Xlocklocklocklock27.951.49.4locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Harvard Bioscience, Inc. (HBIO:NAS)?
Halo FAQ
The current share price of Harvard Bioscience, Inc. (HBIO:NAS) is USD$5.40.
What is the 52-week high share price for Harvard Bioscience, Inc. (HBIO:NAS)?
Halo FAQ
The 52-week high share price for Harvard Bioscience, Inc. (HBIO:NAS) is USD$9.46.
What is the 52-week low share price for Harvard Bioscience, Inc. (HBIO:NAS)?
Halo FAQ
The 52-week low share price for Harvard Bioscience, Inc. (HBIO:NAS) is USD$2.81.
What is the dividend yield for Harvard Bioscience, Inc. (HBIO:NAS)?
Halo FAQ
Harvard Bioscience, Inc. (HBIO:NAS) does not pay a dividend.
What was Harvard Bioscience, Inc. (HBIO:NAS) last dividend payment?
Halo FAQ
Harvard Bioscience, Inc. (HBIO:NAS) does not pay a dividend.
What is the franking level for Harvard Bioscience, Inc. (HBIO:NAS)?
Halo FAQ
Harvard Bioscience, Inc. (HBIO:NAS) has a franking level of 0.00%.
In which sector is Harvard Bioscience, Inc. (HBIO:NAS) classified?
Halo FAQ
Harvard Bioscience, Inc. (HBIO:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Harvard Bioscience, Inc. (HBIO:NAS)?
Halo FAQ
The current P/E ratio for Harvard Bioscience, Inc. (HBIO:NAS) is 16.90.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial